Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Softening hard masses and dissipating stagnation (known as Ruanjian Sanjie in Chinese) is a foundational therapeutic principle in Traditional Chinese Medicine (TCM) used to treat various hard pathological masses, including malignant tumors, cysts, and goiters [2]. It is not a specific molecular target or receptor but a therapeutic category of herbal formulations, such as the Ruanjian Sanjie decoction, which typically includes medicinal herbs like Prunella vulgaris and Sargassum [4][5]. These formulations work synergistically to resolve phlegm, eliminate blood stasis, and soften hardened tissues through multiple biological pathways rather than a single site of action [2]. In oncology, this principle is applied to induce tumor cell apoptosis and sensitize cancer cells to conventional therapies like chemotherapy and radiotherapy while reducing systemic toxicity [4][6]. Clinically, it is frequently employed for the management of breast cancer, thyroid hyperplasia, and uterine fibroids, demonstrating a broad spectrum of anti-proliferative and anti-inflammatory activities in modern pharmacological studies [3][5].
The mechanism involves the suppression of anti-apoptotic proteins such as Bcl-2 and survivin, leading to the activation of the caspase-3/7 and caspase-9 apoptotic cascades [2][4]. Formulations based on this principle also target pathways involved in cell proliferation and invasion, including the inhibition of the PI3K/Akt/mTOR and Wnt/β-catenin signaling pathways, and the regulation of the Smad3/Smad7 cascade to inhibit epithelial-mesenchymal transition [3][5][6].
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Softening hard masses and dissipating stagnation (RJSJ).